Taiwan-based startup Anbogen secures $12.5 M for advancing precision oncology drug development
Amount Raised
$12.5 Million
Round Type
Funding Round
TaipeiBiotechnologyInvestors
Description
Taiwan-based startup Anbogen Therapeutics has completed its Series A funding round, securing approximately $12.5 million for advancing precision oncology drug development. The lead investor is China Development Industrial Bank (CDIB), with significant contributions from Taian Venture Capital, Maxpro and the National Development Fund.
Quick answer
Anbogen Therapeutics raised $12.5 Million in a Funding Round round, dated February 2, 2024. Investors: National Development Fund, Maxpro, Taian Venture Capital and China Development Industrial Bank (Cdib). Anbogen Therapeutics is based in Taipei, Taipei City, Taiwan.
- How much did Anbogen Therapeutics raise?
- Anbogen Therapeutics raised $12.5 Million in a Funding Round round on February 2, 2024.
- Who invested in Anbogen Therapeutics?
- National Development Fund, Maxpro, Taian Venture Capital and China Development Industrial Bank (Cdib) are named as investors in this round.
- What does Anbogen Therapeutics do?
- Anbogen Therapeutics is a clinical stage precision oncology company dedicated in developing first/best-in-class personalized therapeutics and making difference in patients' life.
- Where is Anbogen Therapeutics based and how big is it?
- Anbogen Therapeutics is based in Taipei, Taipei City, Taiwan.
- Who are the decision-makers at Anbogen Therapeutics?
- Fundz holds 1 contact at Anbogen Therapeutics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology around the same time
Companies in the same sectors as Anbogen Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- UpHill Health raised $7M (Funding Round) on March 18, 2024.
- BrickBio raised an undisclosed amount (Funding Round) on March 18, 2024.
- Aprea Therapeutics raised $34M (Funding Round) on March 18, 2024.
- CryoLogyx raised $637K (Seed) on March 18, 2024.
- Spineart raised $21M (Convertible Note) on March 18, 2024.
- ConKay Medical Systems raised $1.8M (Seed) on March 18, 2024.
Who to call at Anbogen Therapeutics, and when
A new round usually means Anbogen Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Anbogen Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Anbogen Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Anbogen Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Anbogen Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Anbogen Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.